Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation: The Last Frontier
Transcatheter aortic valve implantation (TAVI) to treat patients with severe symptomatic aortic stenosis is a well-established procedure. Even though cases series have reported TAVI use in high-risk patients with pure native aortic regurgitation, this is still considered an off-label intervention, e...
Main Authors: | Ana Paula Tagliari, Rodrigo Petersen Saadi, Eduardo Keller Saadi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/17/5181 |
Similar Items
-
Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves
by: Hideyuki Kawashima, et al.
Published: (2021-03-01) -
TAVI for Pure Non-calcified Aortic Regurgitation Using a Self-Expandable Transcatheter Heart Valve
by: Yvonne Schneeberger, et al.
Published: (2022-01-01) -
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom
by: Mauro Chiarito, et al.
Published: (2022-07-01) -
Pre‐Implantation Balloon Aortic Valvuloplasty and Clinical Outcomes Following Transcatheter Aortic Valve Implantation: A Propensity Score Analysis of the UK Registry
by: Glen P. Martin, et al.
Published: (2017-02-01) -
Setting up a transcatheter aortic valve implantation program: Indian perspective
by: John Jose, et al.
Published: (2016-09-01)